| Enzyme responsive drug delivery systems in cancer treatment M Shahriari, M Zahiri, K Abnous, SM Taghdisi, M Ramezani, M Alibolandi Journal of Controlled Release 308, 172-189, 2019 | 274 | 2019 |
| Targeted MMP-2 responsive chimeric polymersomes for therapy against colorectal cancer P Ramezani, K Abnous, SM Taghdisi, M Zahiri, M Ramezani, M Alibolandi Colloids and surfaces B: Biointerfaces 193, 111135, 2020 | 55 | 2020 |
| Hybrid nanoreservoirs based on dextrancapped dendritic mesoporous silica nanoparticles for CD133targeted drug delivery M Zahiri, M Babaei, K Abnous, SM Taghdisi, M Ramezani, M Alibolandi Journal of Cellular Physiology 235 (2), 1036-1050, 2020 | 41 | 2020 |
| Aptamer targeted red blood cell membrane-coated porphyrinic copper-based MOF for guided photochemotherapy against metastatic breast cancer M Falsafi, M Zahiri, AS Saljooghi, K Abnous, SM Taghdisi, A Sazgarnia, ... Microporous and Mesoporous Materials 325, 111337, 2021 | 30 | 2021 |
| Theranostic nanobubbles towards smart nanomedicines M Zahiri, S Taghavi, K Abnous, SM Taghdisi, M Ramezani, M Alibolandi Journal of Controlled Release 339, 164-194, 2021 | 29 | 2021 |
| Thermosensitive composite hydrogel incorporated with curcumin-loaded nanopolymersomes for prolonged and localized treatment of glioma M Babaei, J Davoodi, R Dehghan, M Zahiri, K Abnous, SM Taghdisi, ... Journal of Drug Delivery Science and Technology 59, 101885, 2020 | 25 | 2020 |
| Fabrication of versatile targeted lipopolymersomes for improved camptothecin efficacy against colon adenocarcinoma in vitro and in vivo M Zahiri, SM Taghdisi, K Abnous, M Ramezani, M Alibolandi Expert Opinion on Drug Delivery 18 (9), 1309-1322, 2021 | 23 | 2021 |
| Surface engineering of hollow gold nanoparticle with mesenchymal stem cell membrane and MUC-1 aptamer for targeted theranostic application against metastatic breast cancer S Taghavi, H Tabasi, M Zahiri, K Abnous, SM Taghdisi, S Nekooei, ... European Journal of Pharmaceutics and Biopharmaceutics 187, 76-86, 2023 | 15 | 2023 |
| Targeted biomimetic hollow mesoporous organosilica nanoparticles for delivery of doxorubicin to colon adenocarcinoma: in vitro and in vivo evaluation M Zahiri, M Falsafi, K Lamei, K Abnous, SM Taghdisi, M Ramezani, ... Microporous and Mesoporous Materials 335, 111841, 2022 | 11 | 2022 |
| A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells E Yaghoobi, TS Zavvar, M Ramezani, M Alibolandi, ... Journal of Drug Targeting 30 (10), 1106-1112, 2022 | 7 | 2022 |
| Marriage of phospholipid and block copolymer in lipopolymersome hybrid structure for efficient tumor accumulation M Zahiri, SM Taghdisi, K Abnous, R Zolfaghari, M Ramezani, M Alibolandi International Journal of Pharmaceutics 591, 120030, 2020 | 4 | 2020 |
| Self-targeted hyaluronic acid-b-poly (β-amino ester) pH-switchable polymersome for guided doxorubicin delivery to metastatic breast cancer M Borhaninia, M Zahiri, K Abnous, SM Taghdisi, M Ramezani, ... International Journal of Biological Macromolecules 248, 125882, 2023 | 3 | 2023 |
| Synthesis of folate targeted theranostic cubosomal platform for co-delivery of bismuth oxide and doxorubicin to melanoma in vitro and in vivo M Zahiri, H Kamali, K Abnous, SM Taghdisi, S Nekooei, N Nekooei, ... European Journal of Pharmaceutics and Biopharmaceutics 198, 114259, 2024 | 2 | 2024 |
